C Poirier1, S Aymeric2, L Grammatico-Guillon3, J P Lebeau4, L Bernard5, P Le Bret6, G Le Moal7, G Gras8. 1. Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France. Electronic address: poirier_claire@yahoo.fr. 2. Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Service d'information médicale d'épidémiologie et d'économie de la santé, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France. Electronic address: sandra.aymeric@univ.tours.fr. 3. Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Service d'information médicale d'épidémiologie et d'économie de la santé, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France. 4. Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Équipe émergente éducation éthique santé, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France; Département universitaire de médecine générale, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France. 5. Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37020 Tours cedex 1, France. 6. Réseau ville hôpital VIH 37, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France. 7. COREVIH centre Poitou-Charentes, service de maladies infectieuses et tropicales, CHRU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers cedex, France. 8. Service de médecine interne et maladies infectieuses, CHRU de Tours, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
Abstract
BACKGROUND: The 2010-2014 HIV/AIDS French program recommends using HIV rapid diagnostic tests in family practice. Our aim was to assess the acceptability and feasibility of the RDT in family practice in France. METHODS: The first part of this study was to determine the opinions of family practitioners (FPs) concerning the news guidelines for screening and the possible use of rapid HIV tests in their practice. The second part was a feasibility study of the actual use of rapid HIV tests given to FPs during six months. The third part was a qualitative analysis of experience feedback to determine the impediments to using rapid HIV tests. RESULTS: Seventy-seven percent of the 352 FPs interviewed were favorable to rapid HIV tests use. The three main impediments were: misinterpretation of test result, complexity of quality control, and lack of training: 23 of the 112 FPs having volunteered to evaluate the rapid HIV tests followed the required training session. Sixty-nine tests were handed out, and three rapid HIV tests were used; the qualitative study involved 12 FPs. The participants all agreed on the difficult use of rapid HIV tests in daily practice. The main reasons were: too few opportunities or requests for use, complex handling, difficulties in proposing the test, fear of having to announce seropositivity, significantly longer consultation. CONCLUSION: Although FPs are generally favorable to rapid HIV tests use in daily practice, the feasibility and contribution of rapid HIV tests are limited in family practice.
BACKGROUND: The 2010-2014 HIV/AIDS French program recommends using HIV rapid diagnostic tests in family practice. Our aim was to assess the acceptability and feasibility of the RDT in family practice in France. METHODS: The first part of this study was to determine the opinions of family practitioners (FPs) concerning the news guidelines for screening and the possible use of rapid HIV tests in their practice. The second part was a feasibility study of the actual use of rapid HIV tests given to FPs during six months. The third part was a qualitative analysis of experience feedback to determine the impediments to using rapid HIV tests. RESULTS: Seventy-seven percent of the 352 FPs interviewed were favorable to rapid HIV tests use. The three main impediments were: misinterpretation of test result, complexity of quality control, and lack of training: 23 of the 112 FPs having volunteered to evaluate the rapid HIV tests followed the required training session. Sixty-nine tests were handed out, and three rapid HIV tests were used; the qualitative study involved 12 FPs. The participants all agreed on the difficult use of rapid HIV tests in daily practice. The main reasons were: too few opportunities or requests for use, complex handling, difficulties in proposing the test, fear of having to announce seropositivity, significantly longer consultation. CONCLUSION: Although FPs are generally favorable to rapid HIV tests use in daily practice, the feasibility and contribution of rapid HIV tests are limited in family practice.
Authors: S Desai; L Tavoschi; A K Sullivan; L Combs; D Raben; V Delpech; S F Jakobsen; A J Amato-Gauci; S Croxford Journal: HIV Med Date: 2019-11-14 Impact factor: 3.180
Authors: Jessika Deblonde; Dominique Van Beckhoven; Jasna Loos; Nicole Boffin; André Sasse; Christiana Nöstlinger; Virginie Supervie Journal: BMC Public Health Date: 2018-10-22 Impact factor: 3.295